Madrigal Pharmaceuticals, Inc. (MDGL) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Madrigal Pharmaceuticals, Inc. (MDGL) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $11.96B, listed on NASDAQ, employing roughly 528 people, carrying a beta of -1.04 to the broader market. Madrigal Pharmaceuticals, Inc. Led by William J. Sibold, public since 2007-02-06.
Snapshot as of May 15, 2026.
- Spot Price
- $526.50
- ATM IV
- 42.9%
- IV Skew 25Δ
- -0.056
- IV Rank
- 13.4%
- IV Percentile
- 4.0%
- Term Structure Slope
- 0.015
As of May 15, 2026, Madrigal Pharmaceuticals, Inc. (MDGL) at-the-money implied volatility is 42.9%. IV rank is 13.4% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 4.0%. The 25-delta skew is -0.056: puts carry meaningful premium over calls, a classic equity downside-protection skew. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
MDGL Strategy Selection at Current Volatility Levels
For Madrigal Pharmaceuticals, Inc. options at 42.9% ATM IV, low IV rank (13.4%) favors premium-buying or long-vol structures: long calls or puts, debit spreads, calendar spreads, long straddles. The risk: low-rank regimes can persist for months while time decay eats premium-buyers alive. The 25-delta skew is meaningfully put-skewed, so put-credit spreads capture more premium for the same width than call-credit spreads. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked MDGL volatility skew questions
- What is the current MDGL ATM implied volatility?
- As of May 15, 2026, Madrigal Pharmaceuticals, Inc. (MDGL) at-the-money implied volatility is 42.9%. IV rank is 13.4% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is MDGL IV high or low historically?
- IV is subdued relative to its 1-year history, conditions that typically favor premium-buying strategies (long calls, long puts, debit spreads, calendar spreads).
- What does MDGL volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Madrigal Pharmaceuticals, Inc. carries the typical equity downside-protection skew: 25-delta puts price meaningfully richer than 25-delta calls. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.